Capsule Summary Slidesets

Share

Program Content

Activities

CAPELLA: LEN in MDR HIV at Wk 104
CAPELLA: Wk 104 Results With Long-Acting Subcutaneous Lenacapavir in Persons Living With Multidrug-Resistant HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 19, 2023

BRIGHTE Wk 240 Update
BRIGHTE Update: Wk 240 Results From Phase III Study of Fostemsavir + OBT in Heavily Treatment–Experienced People on Failing ART Regimens
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 19, 2023

HBV Reactivation After ART Switch
HBV Reactivation After Switch to ART Lacking HBV Activity: Results in Persons With Hepatitis B Core Antibody Positivity
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 20, 2023

GLP-1 RAs and Weight Loss in HIV
Impact of GLP-1 Receptor Agonists on Weight Loss in People Living With HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 20, 2023

SC LEN PK by Administration Site
Clinical Pharmacokinetics of Subcutaneous Lenacapavir: Impact of Administration Sites
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 23, 2023

OPERA: CAB + RPV by BMI
OPERA Subset: Effectiveness of LA CAB + RPV in Virologically Suppressed, Treatment-Experienced People Living With HIV, Stratified by BMI
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 23, 2023

DOR Resistance in HIV
Real-world Prevalence and Impact of DOR-Related Resistance Mutations Among NNRTI-Naive and Experienced Persons Living With HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 23, 2023

Representation LA ART Studies
Representation of Women, Black People and People of Color, and Older Adults in Studies Evaluating Long-Acting Antiretroviral Therapy
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 25, 2023

Provided by

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare